Fundz
Funding, M&A and exec moves matched to your market, from $49/mo billed annually, or $79/mo quarterly. See plans and pricing.See plans →

Edwards Lifesciences completes acquisition of Innovalve

PRIVATESep 09, 2026about 3 hours ago

Acquiring Company

Edwards Lifesciences

Acquired Company

Innovalve

IrvineIsraelManufacturingBiotechnologyHealthcareHealth CareArtificial IntelligenceMedicalMedical DeviceBiotechnologyHealth CareMedicalMedical Device

Description

Edwards Lifesciences has acquired Innovalve for approximately $300 million in cash. This acquisition follows a previous investment made by Edwards in Innovalve in 2017. The acquired technology aims to revolutionize mitral valve replacement procedures without open-heart surgery. Innovalve's system has shown promising results in initial human trials.

Company Information

Company

Edwards Lifesciences

Location

One Edwards Way

Irvine, California, United States

About

Edwards Lifesciences is the global leader of patient-focused innovations for structural heart disease and critical care monitoring. The company is dedicated to improving and enhancing lives through partnerships with clinicians and stakeholders across the global healthcare landscape.

Don't miss Edwards Lifesciences's next move

Get an email the moment Edwards Lifesciences makes an acquisition, hires an exec, or expands, usually minutes after it happens.

One email per event. Unsubscribe anytime.

Related People

Tiago
Likely contact at this company
••••••••@••••••••

See Tiago's verified email →

Pierre
Senior decision-maker at this company
••••••••@••••••••

See Pierre's verified email →

Predictive Intelligence
Strategic

ML-powered predictions for Edwards Lifesciences's next move

Learn about Strategic plan

M&A Insights

Based on deal data
Integration timeline
70% of M&A integrations take 12-24 months to complete
Tech stack consolidation
83% of merged companies consolidate technology vendors within first year
Post-acquisition investment
Companies increase IT spending by 23% on average after acquisitions
Success factor
M&A deals with strong technology integration plans are 2.5x more likely to succeed

Frequently asked

Who acquired Innovalve?

Innovalve was acquired by Edwards Lifesciences, based in Irvine. The deal was reported on September 9, 2026. Edwards Lifesciences is the global leader of patient-focused innovations for structural heart disease and critical care monitoring. Edwards Lifesciences is privately held and operates in Manufacturing.

When did Edwards Lifesciences acquire Innovalve?

Edwards Lifesciences's acquisition of Innovalve was reported on September 9, 2026. Edwards Lifesciences has acquired Innovalve for approximately $300 million in cash. This acquisition follows a previous investment made by Edwards in Innovalve in 2017. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.

What does Innovalve do?

Innovalve is a medical technology company developing a catheter-based system for mitral valve replacement without the need for open-heart surgery. It is privately held, operating in Biotechnology, and is based in Israel.

This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.

145 of these a day, filtered to the companies you pick. $29 a month, billed annually, and if it does not pay for itself in a year we refund it.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 285,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.